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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanBackground/Purpose: Diagnosis of catheter-related bloodstream infection (CRBSI) requires
specific laboratory evidence. A simpler definition, central line-associated bloodstream infec-
tion (CLABSI), is recommended for surveillance purposes. Because exclusion of all other infec-
tion sources is difficult, CRBSI cases may be overestimated by using the CLABSI definition.
Methods: A retrospective observational study was performed at a regional hospital in southern
Taiwan from September 2012 to December 2013. All 106 reported CLABSI cases were assessed.
Cases with catheter tip cultures were reviewed. CRBSI was defined as the identification of
same organisms from the paired blood and catheter tip cultures (15 colony-forming units)
without evidence of secondary bacteremia from other infection sources.
Results: Overall, 64 cases were included and 31 (48.4%) were defined as CRBSI cases. In 30
(46.9%) cases, catheter tips were cultured after the corresponding blood cultures were per-
formed. Later tip cultures were significantly more frequent in cases with other catheter types
(18/22, 81.8%) than those with central lines (12/42, 28.6%; p < 0.0001). The same significant
difference was also found among the CRBSI cases (central lines, 3/17, 17.6%; others, 13/14,
92.9%; p < 0.00005). Twelve bacterial species were identified from the CRBSI cases, witht of Laboratory Medicine, Chang Gung Memorial Hospital, Number 5, Fu-Hsin Street, Kweishan,
of Infection Control, Tainan Municipal Hospital, Number 670, Chung Te Road, Tainan 701, Taiwan.
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626 X.-X. Chen et al.Staphylococcus aureus being the most frequent (13, 41.9%), followed by Pseudomonas aerugi-
nosa (5, 16.1%).
Conclusion: The positive predictive value of the CLABSI definition for CRBSI cases was 48.4%.
One should be aware of this discrepancy and should interpret the CLABSI surveillance definition
with care.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Catheter-related bloodstream infection (CRBSI) is an
important healthcare-associated infection. It may increase
medical expenses,1 may lengthen hospitalization period by
7e21 days,2 and is associated with a higher mortality of
12e25%.3 Reports have indicated that CRBSI is pre-
ventable.3e5 Therefore, BSI bundle intervention has been
established widely to eliminate CRBSI,6e8 with an ultimate
goal of achieving a zero CRBSI rate in clinical settings.5,9
The fundamental diagnosis of a CRBSI is the documen-
tation of bacteremia, followed by demonstrating that the
central venous catheters (CVCs) are the source of the
infection. Exclusion of other potential primary infection
foci is required for defining a true CRBSI.10 Generally, three
methods are recommended for the diagnosis of CRBSI.11
The first method is catheter tip culture (CTC) by a semi-
quantitative method.12 CTC with a growth (15 colony-
forming units, CFU) of the same microbial organisms as
that from the peripheral blood culture is considered a
definitive diagnosis for CRBSI.13,14 The second one is esti-
mation of the ratio of quantitative culture (RQC). It is
estimated by comparing the bacterial growth of a pair of
blood specimens that were drawn, respectively, from a
catheter and from a peripheral vein at the same time. If
both cultures grow the same organisms and the colony
counts from the catheter-drawn blood is five (or at least 3)
times greater than that drawn by venipuncture, then it is
considered a confirmatory diagnosis for CRBSI.11,14 The last
method is to evaluate the differential time to positivity
(DTP). The definition of DTP is similar to that of RQC,
except that it compares the times required for a positive
growth of the same organisms from the two blood cultures.
If the time to positive growth is at least 2 hours earlier for
the catheter-drawn blood compared to that for the blood
drawn by venipuncture, then it is also considered a
confirmatory diagnosis for CRBSI.14,15 Among the three
methods, CTC is used most commonly in clinical microbi-
ology laboratories due to the simplicity of the method.
However, it requires removal of the catheter. By contrast,
RQC and DTP do not need to remove the catheter, but they
are not performed routinely in laboratories due to their
technical complexity.
According to the guideline from the Centers for Disease
Control and Prevention (CDC) in the USA, CRBSI is a clinical
definition used for the diagnosis and treatment of patients
who develop bacteremia while using CVCs.10 As described
above, the precise diagnosis of CRBSI is not easy. For the
purpose of surveillance or monitoring of such infections,
another system, central line-associated bloodstreaminfection (CLABSI), was used by CDC’s National Healthcare
Safety Network (NHSN).16 A CLABSI is defined as a primary
BSI in a patient with central lines (CLs) within the 48-hour
period prior to the onset of the BSI, and the BSI is not
related to any infection at other foci. Since the identifi-
cation and exclusion of all the associated infection sources,
other than CVCs, that may predispose the patient to the BSI
are difficult, true CRBSI cases may be overestimated by
using the CLABSI surveillance definition.3,10 However, re-
ports to delineate the extent of this discrepancy remains
sporadic.
Tainan Municipal Hospital is a 622-bed regional hospital
in southern Taiwan. Since September 2012, the hospital has
started to collect the number of CLABSI cases per month
and report to the Centers for Disease Control in Taiwan
(Taiwan CDC). The reporting criteria defined by the Taiwan
CDC are based on the NHSN CLABSI surveillance definition
defined in 2008.16,17 Up to December 2013, 106 cases have
been reported. However, prior to the use of the CLABSI
definition, only about two CRBSI cases per month were
noted. The present study was therefore conducted to
elucidate whether the sudden increase to an average of 6.6
cases per month was due to the overestimation by using the
CLABSI surveillance definition.
Methods
This is a retrospective observational study. For the diag-
nosis of CRBSI, the standard CTC method is routinely per-
formed in the clinical microbiology laboratory of this
hospital. Therefore, CTC results were used to define true
CRBSI cases among the CLABSI cases. From September 2012
to December 2013, a total of 106 CLABSI cases were iden-
tified to fulfill the CLABSI definition16,17 and reported to
Taiwan CDC by the infection control personnel. From them,
records of CTCs performed after or within 2 days prior to
the specimen date of the positive blood cultures were
examined. If a CTC grew 15 CFU of the same microbial
organism as that identified from the corresponding blood
culture, the case would be defined as a CRBSI.
Medical records of the CLABSI cases with CTCs were
reviewed. Information regarding demographic data; types
of CVCs, including CLs, double lumens, permanent cathe-
ters, Port-A-Caths, and peripherally inserted central cath-
eters; and clinical presentations or diagnosis at the removal
of the catheter tips was collected for comparison. The
correctness of the designation of CLABSI cases was also
checked. Results of bacterial cultures from other speci-
mens and imaging examinations, such as sonograms, chest
X-rays, etc., of these cases within 7 days prior to or after
CRBSI cases overestimated by CLABSI surveillance definition 627the specimen dates of the corresponding positive blood
cultures were examined to exclude the possibility of sec-
ondary bacteremia originating from other infection
sources.
For statistical analysis, the Chi-square test was used. A
difference was considered statistically significant when
p < 0.05.Results
Of the 106 reported CLABSI cases, 39 (36.8%) did not have
corresponding CTCs. Whether or not they were also CRBSI
cases could not be confirmed. Among the other 67 cases
with CTCs, one was further excluded from the CLABSI
category because, according to the medical records, the
catheter tip was removed and sent for microbial cultures
about 57 hours earlier than that of the blood culture. The
case would otherwise be considered as a CRBSI because
Proteus mirabilis was identified from both blood cultures
and CTCs (15 CFU). Another two cases were also excluded
from the CLABSI category because they had other infection
foci, one with urinary tract infection caused by Candida
tropicalis and the other with wound infection caused by
Acinetobacter baumannii and Stenotrophomonas malto-
philia. The same organisms were also identified from their
corresponding paired blood cultures and CTCs (both
15 CFU), respectively.
Among the64 cases included for study, 31 (48.4%; Y1eY31)
were found to have the same organisms identified from their
paired blood cultures and CTCs (15 CFU) and thus were
further categorized as CRBSI cases (Table 1). Therefore, the
positive predictive value of the CLABSI definition for CRBSI
cases was 48.4%. All of the 64 cases were adults, aged be-
tween 40 years and 90 years, and 38 were male patients.
Fever was found in 58 cases, and six cases had septic shock at
the time of catheter removal (Tables 1 and 2). These de-
mographic and clinical characteristics were similar between
the CRBSI and non-CRBSI cases.
The most common CTCs were from CLs (n Z 42), fol-
lowed by Port-A-Caths (n Z 10), double lumens (n Z 8),
permanent catheters (n Z 3), and peripherally inserted
central catheters (n Z 1). In 34 (53.1%) cases, the paired
blood and catheter tip specimens were submitted for mi-
crobial cultures simultaneously, and 15 (44.1%) of them
were defined as CRBSI subsequently. In the remaining 30
(46.9%) cases, the catheter tips were removed and sub-
mitted for cultures about 1e8 days after the corresponding
blood cultures were performed. Sixteen (53.3%) of these
cases were further categorized as CRBSI. Although the
proportion of CRBSI cases was lower in the former group in
which blood and tip specimens were submitted simulta-
neously, the difference was not statistically significant
(p Z 0.4616). Furthermore, among the 42 cases with CLs,
12 (28.6%) were found to have tip cultures later than the
corresponding blood cultures. By contrast, the proportion
(18 cases, 81.8%) was significantly larger in the remaining
22 cases with other catheter types (p < 0.0001). When only
the 31 CRBSI cases were compared, later tip cultures were
found in three (17.6%) of the 17 cases using CLs; the pro-
portion (13 cases, 92.9%) was significantly larger among the
14 cases with other catheter types (p < 0.00005; Table 1). Itis also noted that the proportion of CRBSI cases was rela-
tively higher among patients who used other catheter types
(14/22, 63.6%) than among those who used CLs (17/42,
40.5%), although the difference was not statistically sig-
nificant (p Z 0.0783).
As shown in Table 1, various bacterial species were
associated with the 31 CRBSI cases, including 18 (58.1%)
Gram-positive organisms (Staphylococcus aureus, 13,
41.9%; other Staphylococcus spp., 4, 12.9%; and Entero-
coccus faecium, 1), eight (25.8%) Gram-negative organisms
(Pseudomonas aeruginosa, 5, 16.1%; A. baumannii, 1;
Klebsiella pneumoniae, 1; and Ralstonia pickettii, 1), and
five (16.1%) Candida spp. (Candida albicans and C. tropi-
calis, 2 each; and Candida parapsilosis, 1). Table 2 dem-
onstrates microbial findings for the 33 non-CRBSI cases.
Compared to that only 12 bacterial species were identified
from the CRBSI cases, microbial spectra were more diverse
in the non-CRBSI cases. A total of 26 bacterial species were
identified from either the blood cultures or the CTCs, with
22 of them being found from the blood cultures.Discussion
In the present study, only 31 (48.4%) of the CLABSI cases
fulfilled the CRBSI criteria. The data showed an average of
1.9 CRBSI cases per month, which was similar to that re-
ported prior to when the CLABSI definition was adapted at
this hospital. The results suggested that, with the use of the
CLABSI surveillance definition, the rate of CRBSI may be
overestimated by approximately 50%. The finding is sur-
prising but not impossible, as a recent study also demon-
strated a low positive predictive value (27.7%) of the CLABSI
surveillance definition.18 Studies have shown that unex-
plained fever is common among critically ill patients.19
Therefore, such a high overestimation rate implied that
the causes of a half of the “suspected” CRBSI cases would
be erroneously attributed to the in-used catheters. Similar
arguments have also been raised by others.20 Accordingly,
the use of the CLABSI surveillance definition to monitor
some infection control measures, e.g., BSI bundle care,
may lead to unsatisfactory consequences, even though
much effort has been made.
More than one-third of the CLABSI cases did not have
corresponding CTCs and therefore were excluded from the
study. This may somehow affect the accuracy of the find-
ings in the present study. As this was a retrospective study,
we were unable to confirm the proportion of CRBSI cases
among the 39 non-catheter-tip-cultured CLABSI cases.
However, even though the 39 cases were all true CRBSI
cases, overestimation of the actual rate by the CLABSI
surveillance definition would still be high at 32.0%. This
high overestimation rate may not be a problem if the
resulting CLABSI case numbers remained at a low and
acceptable range. However, if the number of reported
CLABSI cases increased unexpectedly, as we have encoun-
tered since the use of the CLABSI definition at this hospital,
CTC or other methods, such as the RQC and DTP, may be
necessary for the suspected CLABSI cases to explore some
potential problems.14
It was noted that some CTCs were performed after
positive results were reported from the corresponding




Blood isolatea BC date CTC date Tip isolatea CFU CVC
Y1 Septic
shock
Staphylococcus aureusa Oct 2, 2012 Oct 2, 2012 S. aureusa >15 CL
Y2 Fever Pseudomonas aeruginosa Oct 11, 2012 Oct 11, 2012 P. aeruginosa >15 CL
Y3 Fever Klebsiella pneumoniaea Oct 19, 2012 Oct 19, 2012 K. pneumoniaea >15 CL
Y4 Fever Candida albicans Oct 22, 2012 Oct 22, 2012 C. albicans Z15 CL
Y5 Fever S. aureus Nov 1, 2012 Nov 3, 2012 S. aureus >15 DL
P. aeruginosa >15
Y6 Fever P. aeruginosa Nov 8, 2012 Nov 8, 2012 P. aeruginosa >15 CL
Acinetobacter baumannii
Staphylococcus hominis
Y7 Fever Staphylococcus capitis Nov 15, 2012 Nov 15, 2012 S. capitis >15 CL
Y8 Septic
shock
S. aureusa Nov 19, 2012 Nov 19, 2012 S. aureusa >15 CL
P. aeruginosa >15
Y9 Fever S. aureus Nov 26, 2012 Nov 27, 2012 S. aureus >15 DL
Y10 Fever S. aureus Dec 5, 2012 Dec 5, 2012 S. aureus >15 CL
Enterobacter cloacae >15
Y11 Fever P. aeruginosa Jan 8, 2013 Jan 8, 2013 P. aeruginosa >15 CL
Y12 Fever A. baumanniia Feb 7, 2013 Feb 7, 2013 A. baumanniia >15 CL
Y13 Fever S. aureus Feb 8, 2013 Feb 9, 2013 S. aureus >15 DL
Y14 Fever Ralstonia pickettii Feb 18, 2013 Feb 21, 2013 R. pickettii >15 Pen cath
Y15 Fever S. aureusa Feb 27, 2013 Feb 27, 2013 S. aureusa >15 PAC
Y16 Fever S. aureusa Apr 6, 2013 Apr 8, 2013 S. aureusa >15 PAC
Y17 Fever P. aeruginosa May 20, 2013 May 27, 2013 P. aeruginosa >15 PAC
S. aureus >15
Y18 Fever Staphylococcus epidermidis May 21, 2013 May 24, 2013 S. epidermidis >15 CL
Y19 Fever Candida parapsilosis May 23, 2013 May 27, 2013 C. parapsilosis >15 PAC
Y20 Fever Enterococcus faeciuma May 26, 2013 May 27, 2013 E. faeciuma >15 CL
C. albicans >15
Y21 Fever S. aureusa Jun 3, 2013 Jun 3, 2013 S. aureusa >15 CL
Y22 Fever S. epidermidis Jul 12, 2013 Jul 12, 2013 S. epidermidis >15 CL
Y23 Fever S. aureus Jul 16, 2013 Jul 19, 2013 S. aureus >15 Pen cath
Y24 Fever Candida tropicalis Aug 1, 2013 Aug 2, 2013 C. tropicalis >15 PAC
Y25 Fever C. tropicalis Aug 5, 2013 Aug 5, 2013 C. tropicalis >15 CL
Coagulase (e) staphylococci
Y26 Fever S. aureusa Aug 21, 2013 Aug 22, 2013 S. aureusa >15 DL
Y27 Fever Coagulase (e) staphylococci Sep 23, 2013 Sep 25, 2013 Coagulase (e)
staphylococci
>15 PICC
Y28 Fever S. aureusa Oct 23, 2013 Oct 24, 2013 S. aureusa >15 CL
Y29 Fever P. aeruginosa Nov 16, 2013 Nov 21, 2013 P. aeruginosa >15 PAC
Serratia marcescens
Y30 Fever S. aureus Nov 18, 2013 Nov 19, 2013 S. aureus >15 PAC
Y31 Fever C. albicans Dec 14, 2013 Dec 14, 2013 C. albicans >15 CL
a Antimicrobial resistance in the bacterium indicated: S. aureus, methicillin resistant; K. pneumoniae, extended-spectrum b-lacta-
mase producing; A. baumannii, carbapenem resistant; and E. faecium, vancomycin resistant.
BCZ blood culture; BSIZ bloodstream infection; CFUZ colony-forming unit; CLZ central line; CRBSIZ catheter-related bloodstream
infection; CTCZ catheter tip culture; CVCZ central venous catheter; DLZ double lumen; PACZ Port-A-Cath; Pen cathZ permanent
catheter; PICC Z peripherally inserted central catheter.
628 X.-X. Chen et al.blood cultures. A previous study indicated that the final
diagnosis of CRBSI was not affected by either immediate
catheter removal or postponement for a watchful waiting
when a CRBSI is suspected.21 Our data support their findings
in demonstrating that CTCs performed later than the cor-
responding blood cultures did not lead to significantdifferences in the diagnosis of CRBSI. Previous reports
revealed that cases with unnecessary catheter removal
could range from 48% to 91%.21 Thus, for the 51.6% non-
CRBSI cases identified in the present study, removal of
catheters may be mostly unnecessary. Therefore, it may be
more practical that CTCs are performed, if necessary, after




Blood isolatea BC date CTC date Tip isolatea CFU CVC
N1 Fever Candida albicans Sep 17, 2012 Sep 17, 2012 Staphylococcus aureusa (Enriched) CL
N2 Fever Acinetobacter spp. Oct 4, 2012 Oct 4, 2012 (No growth) CL
N3 Fever C. albicans Oct 21, 2012 Oct 26, 2012 (No growth) PAC
N4 Septic
shock
Enterococcus faecium Oct 27, 2012 Oct 27, 2012 Enterococcus spp. >15 DL
N5 Fever Klebsiella pneumoniaea Nov 21, 2012 Nov 21, 2012 K. pneumoniaea (Enriched) CL
Candida glabrata >15
N6 Fever Pseudomonas aeruginosa Nov 28, 2012 Nov 28, 2012 P. aeruginosa (Enriched) CL
N7 Fever Escherichia coli Dec 3, 2012 Dec 3, 2012 K. pneumoniae (Enriched) CL
Klebsiella ozaenae





K. pneumoniaea Jan 8, 2013 Jan 8, 2013 Candida tropicalis >15 CL
N10 Fever Enterobacter cloacae Jan 22, 2013 Jan 24, 2013 Enterococcus faecalis >15 CL
Klebsiella oxytocaa >15
S. aureusa >15
N11 Fever Serratia marcescens Jan 24, 2013 Feb 1, 2013 S. marcescens (Enriched) CL
N12 Fever Candida parapsilosis Jan 25, 2013 Jan 25, 2013 C. glabrata >15 CL
N13 Fever P. aeruginosa Jan 28, 2013 Jan 30, 2013 C. albicans (Enriched) CL
N14 Fever S. epidermidis Feb 10, 2013 Feb 10, 2013 Staphylococcus
saprophyticus
>15 CL
N15 Fever Enterococcus faeciuma Feb 21, 2013 Feb 27, 2013 Acinetobacter
baumanniia
(Enriched) CL
N16 Fever Klebsiella oxytocaa Feb 22, 2013 Feb 22, 2013 K. pneumoniaea >15 CL
N17 Fever E. faecium Mar 20, 2013 Mar 20, 2013 Enterococcus spp. >15 DL
N18 Fever Staphylococcus
haemolyticus
Mar 31, 2013 Apr 1, 2013 C. albicans >15 CL
N19 Fever Streptococcus mutans May 4, 2013 May 4, 2013 S. epidermidis >15 DL
N20 Fever Alcaliggenes faecalis May 27, 2013 May 27, 2013 (No growth) CL
N21 Fever Brevundimonas spp. Jul 4, 2013 Jul 4, 2013 Enterococcus spp. >15 CL
N22 Fever S. aureus Jul 12, 2013 Jul 16, 2013 (No growth) CL
N23 Fever Citrobacter kerosi Sep 24, 2013 Sep 25, 2013 (No growth) CL
N24 Fever A. baumannii Oct 11, 2013 Oct 15, 2013 A. baumannii 1 DL
N25 Fever P. aeruginosa Oct 20, 2013 Oct 21, 2013 (No growth) CL
N26 Fever S. aureusa Oct 22, 2012 Oct 29, 2012 S. aureusa 1 Pen cath
N27 Fever E. cloacae Oct 30, 2013 Nov 1, 2013 (No growth) CL
N28 Septic
shock
A. baumanniia Nov 17, 2013 Nov 17, 2013 A. baumanniia 3 CL




Nov 18, 2013 Nov 18, 2013 (No growth) CL
N31 Fever A. baumannii Nov 18, 2013 Nov 22, 2013 (No growth) PAC
N32 Fever P. aeruginosa Nov 23, 2013 Nov 28, 2013 C. albicans >15 PAC
N33 Septic
shock
Enterococcus spp. Dec 27, 2013 Dec 27, 2013 (No growth) CL
a Antimicrobial resistance in the bacterium indicated: S. aureus, methicillin resistant; K. pneumoniae and K. oxytoca, extended-
spectrum b-lactamase producing; A. baumannii, carbapenem resistant; and E. faecium, vancomycin resistant.
BCZ blood culture; BSIZ bloodstream infection; CFUZ colony-forming unit; CLZ central line; CRBSIZ catheter-related bloodstream
infection; CTCZ catheter tip culture; CVCZ central venous catheter; DLZ double lumen; PACZ Port-A-Cath; Pen cathZ permanent
catheter.
CRBSI cases overestimated by CLABSI surveillance definition 629positive growth is reported for the corresponding blood
cultures, to prevent unnecessary catheter removals.21
Compared to CLs, the other catheters were more likely
to be cultured later than the corresponding bloodcultures, especially among the CRBSI cases. The tech-
niques required for the placement of these catheters are
relatively more complicated than that for CLs. Therefore,
when a CLABSI is suspected in patients using such
630 X.-X. Chen et al.catheters, physicians may be more hesitant in deciding
whether to remove the catheters. However, both the
difficulty in placement of such catheters and the tendency
toward their longer usage may add to their risk of causing
CRBSI.22 Therefore, when a suspected CLABSI is related to
the use of such catheters, it is very likely that a true CRBSI
is encountered. Data in the present study also demon-
strated that the proportion of CRBSI cases was relatively
higher in cases using other catheter types than those using
CLs. In order to initiate an appropriate treatment
promptly, the use of methods such as RQC and DTP has
been suggested for a differential diagnosis.14 In hospitals
where these two techniques are not available, catheters
are suggested to be removed and cultured for timely
diagnosis and treatment.
One of the major criteria for defining either CLABSI or
CRBSI is the exclusion of other associated infection sour-
ces.16 In the present study, two CLABSI cases, which would
otherwise be categorized as CRBSI cases, were excluded
due to the existence of other concurrent infection sour-
ces. However, whether the infections at other foci were
due to bacterial seeding from the bloodstreams or trans-
location of bacteria from the distal infection foci into
bloodstreams and their subsequent colonization of the
catheter tips could not be confirmed.23 Reports also indi-
cated that bloodstream infections occurring in patients
with postchemotherapy neutropenia are frequently due to
the translocation of intestinal organisms; however, these
infections would still be categorized as CLABSI if they
meet the NHSN CLABSI definition.24 Accordingly, the
CLABSI surveillance definition has been revised in 2013 to
reduce the inappropriate inclusion of CLABSI cases asso-
ciated with bacterial translocation.25 Still, suggestions
regarding the exclusion of other subgroups of patients,
e.g., intra-abdominal surgery patients, or some specific
microorganisms, e.g., Escherichia coli, were subsequently
reported.26 By contrast, accumulating studies also
demonstrated that substantial variability could exist
among infectious-diseases physicians and infection control
personnel in the interpretation and application of the
CLABSI surveillance definition.27e29 To apply the CLABSI
definition accurately and effectively, as well as to include
only the infections relevant to infection control practices,
further refinement of the CLABSI definition appears
inevitable.
In conclusion, minimization of the possibility of CRBSI
occurrence is important for patient safety, and many ef-
forts have been made to achieve this goal. To reflect the
effectiveness of such efforts, an accurate evaluation or
consistent monitoring system is also vital. The CLABSI sur-
veillance definition has been used in this hospital for just
over 1 year. Our study may be limited by the small case
number and its retrospective nature, but the gap between
CLABSI and CRBSI has been clearly demonstrated. With a
longer observation period or a larger prospective study to
include data from multiple medical institutions, a more
precise conclusion may be obtained. Prior to suggesting a
better resolution, the infection control personnel and the
associated authority should be aware of this discrepancy,
and the CLABSI surveillance definition should be inter-
preted and applied with care.Conflicts of interest
All contributing authors declare no conflicts of interest.References
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